Cite
HARVARD Citation
Yarur, A. et al. (n.d.). P573 Real-world effectiveness and safety of vedolizumab and anti-TNF in biologic-naive ulcerative colitis patients: Results from the EVOLVE study. Journal of Crohn's and colitis. pp. S400-S401. [Online].